Searched for
FLUTICASONE INHALER
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...- New GST rates from today, September 22: Check the full list to see what’s cheaper and what’s costlierNew GST Rates Full List: India's revised GST structure, effective today, reduces taxes on nearly 400 goods and services, including food, au...
- GSK launches once daily, single inhaler-triple therapy for COPD patientsTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is...
- Glenmark Pharma launches COPD treatment inhaler in UKDrug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstru...
- Trending stocks: Cipla shares gain over 3%A total of 292,263 shares changed hands on the counter till 11:00AM (IST).
- Cipla submits application with USFDA for generic version of asthma drugDrug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...
- Market Movers: Lupin, Sun Pharma soar; RBL plunges; ‘buy’ signal in 171 stocksHere is a lowdown of the movers and shakers of Friday’s session on Dalal Street.
- Cipla jumps 8% on completing Phase-3 clinical study of asthma drugThe generic would be used for treatment of asthma and chronic obstructive pulmonary disease.
- Stocks in the news: RIL, Aurobindo Pharma, Hero MotoCorp, Adani Ports, Future Retail and ONGCStrides Pharma said it has ceased distribution of its ranitidine tablets in the US market.
- Glenmark Pharma rallies on Germany marketing nodThe drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.
- Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western EuropeThis is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...
- Glenmark Pharma launches generic version of asthma drug in DenmarkThe product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.
- Glenmark Pharmaceuticals inks pact with Celon for generic Seretide AccuhalerAs per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries
- GSK halves seretide price to take on CiplaAsthma patients may breathe easier as GSK has halved the prices of its Seretide inhaler in India to match that of Cipla’s competing brand S...
- Lupin ties up with Poland-based firm for generic asthama drugLupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...
- Stock diagnosis: Is Cipla a good buy for investors post Q3?According to analysts, rollout of inhalers in Europe and supplies of esomeprazole (Nexium) to Teva will be key triggers for the stock in co...
- Cipla announces commercial tie-up with UK's S&D PharmaPharmaceutical firm Cipla today announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.
- Top 10 Nifty stocks that surged upto 42% since PM Narendra Modi took chargeThe rally post polls was led by cyclicals on anticipation of reforms. However, investors continued to churn portfolios post the earnings se...
- Brokerages raise Cipla's target price post inhaler launchAnalysts at Emkay Global Financial Services are of the view that the launch will have a strong positive impact on the company’s margins.
- Ranbaxy launches new drug for asthmaRanbaxy Laboratories Ltd on Tuesday announced the launch of its branded product, Avessa inhalation capsules in India for the treatment of A...
Load More
